2025年全球植入市场报告

近年来，植入市场规模强劲成长，从2024年的1,254.8亿美元增加至2025年的1,369.6亿美元，复合年增长率达9.1%。这段历史时期的成长归因于人口老化、慢性病增加、外科手术增多、预期寿命延长以及监管支持和标准。

预计未来几年植入市场将快速成长，到2029年将达到2,073.3亿美元，复合年增长率为10.9%。预测期内的成长归因于客製化和个人化、微创手术的兴起、向再生医学、远端监控和远端医疗的转变，以及有利的法规环境。预测期内的主要趋势包括客製化和个人化植入、可生物降解和生物可吸收植入、生物材料、再生医学和组织工程的进步、智慧植入以及穿戴式技术。

植入是由人体或动物性材料以及生物合成材料製成的先进医疗设备或假体器官。这些植入发挥重要作用，例如替换缺失组织、支撑受损生物结构以及最终增强人体的生物功能。植入有助于辅助和调节人体的各种生理功能。

植入包括几种主要类型，包括心血管植入、人工植牙、脊椎植入、整形外科植入和眼科植入。心血管植入（例如心臟瓣膜和冠状动脉支架）在治疗心臟併发症方面发挥重要作用，旨在留在患者体内并支持健康的血管和正常的心臟功能。植入由各种材料製成，包括金属、陶瓷、聚合物和生物成分。它们来自各种来源，包括同种异体移植、自体移植、异质骨移植和合成材料。这些植入应用于各种医疗保健环境，包括门诊手术中心、诊所、医院和其他最终用户设施。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供植入市场统计数据，包括全球植入市场规模、各地区市场份额、植入的市场份额、详细的植入细分市场、市场趋势和商业机会，以及您在植入行业取得成功所需的数据。本植入市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的全方位观点。

未来五年的预测成长率为10.9%，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这项影响将直接影响美国，因为义大利和瑞典的医用级钛和生物相容性涂层供应受限，这可能会推迟整形外科和牙科植入手术，并增加患者的费用。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，这一影响也将更加广泛地显现。

预计未来几年，慢性病盛行率的上升将推动植入市场的成长。慢性病，包括心血管疾病和关节炎，指持续时间超过一年、需要持续治疗且限制日常活动的疾病。植入在管理和监测此类慢性病方面发挥关键作用，有助于降低与此类疾病相关的死亡率。例如，2024 年 7 月，澳洲健康与福利研究所报告称，慢性阻塞性肺病) 将成为 2022 年澳洲的主要死因，造成 7,691 人死亡，即每 100,000 人口中有 29.6 人死亡，占所有死亡人数的 4.0%。因此，慢性病盛行率的上升正在推动植入市场的成长。

随着高龄化社会的到来，老年人口比例不断增加，植入市场也随之成长。植入透过各种应用解决与老龄化相关的健康问题，包括即时健康监测、药物传递和组织再生。根据世界卫生组织 (WHO) 2022 年 10 月发布的预测，到 2030 年，全球六分之一的人预计将年满 60 岁或以上，这标誌着人口结构的重大变化。这种人口结构变化，即 60 岁及以上人口数量从 2020 年的 10 亿增加到 14 亿，清楚地表明了对植入的需求不断增长。到 2050 年，全球 60 岁及以上人口预计将翻一番，达到 21 亿。人口老化是植入市场扩张的主要驱动力。

技术进步是植入市场的前沿，主要参与者专注于创新的生物材料技术，尤其是用于植入系统的3D列印技术。与传统的金属和聚合物不同，这种积层製造利用细胞和生物材料来创建3D结构。一个值得注意的例子是赢创工业股份公司于2022年3月推出的骨传导性VESTAKEEP iC4800 3DF PEEK长丝。这种高性能聚合物基于3D列印技术，可促进骨骼与植入之间的骨整合，加速骨癒合。其显着特性包括优异的生物相容性、生物稳定性和增强的骨传导性，体现了植入领域技术创新的前沿。

植入市场包括商用支架、心律调节装置、生物製药、创伤植入、运动医学、胸腔植入、椎间间隔器、机械加工同种异体移植间隔器、运动保护植入。此市场的价值是指“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球植入：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
• 最终用途产业分析
• 全球植入市场：成长率分析
• 全球植入市场表现：规模与成长，2019-2024
• 全球植入市场预测：2024-2029年及2034年规模与成长
• 全球植入：总目标市场（TAM）

第六章 市场细分

• 全球植入市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 心血管植入
• 人工植牙
• 脊椎植入
• 整形外科植入
• 眼科植入
• 其他类型
• 全球植入市场：按材料、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 金属
• 陶瓷製品
• 聚合物
• 生物
• 全球植入市场（按来源、表现和预测），2019-2024 年、2024-2029 年、2034 年
• 同种异体移植
• 自体移植
• 异种移植
• 合成
• 全球植入市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
• 门诊手术中心
• 诊所
• 医院
• 其他最终用户
• 全球植入市场：心血管植入的细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 支架
• 心臟瓣膜
• 起搏器
• 全球植入市场：依人工植牙类型细分，实际状况及预测，2019-2024 年、2024-2029 年、2034 年
• 骨内植入
• 骨膜下植入
• 颧骨植入
• 全球植入市场：脊椎生物植入物的植入（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 脊椎固定器
• 椎间盘
• 脊椎棒和板
• 全球植入市场：整形外科植入细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 关节重建植入
• 骨折固定装置
• 接骨板和螺丝
• 全球植入市场：眼科植入细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 人工水晶体（IOL）
• 视网膜植入
• 角膜植入
• 全球植入市场：按类型、其他、实际和预测细分，2019-2024 年、2024-2029 年、2034 年
• 人工电子耳
• 组织工程植入
• 生物材料支架

第七章 区域和国家分析

• 全球植入市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
• 全球植入市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

• 植入市场：竞争格局
• 植入市场：公司简介
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Dentsply Sirona Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

• Arthrex Inc.
• Boston Scientific Corporation
• Smith & Nephew PLC
• B. Braun Melsungen AG
• Victrex PLC
• Straumann Holding AG
• Danaher Corporation
• Cardinal Health Inc.
• Organogenesis Holdings Inc.
• Exactech Inc.
• Osprey Medical Inc.
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• aap Implantate AG
• Abbott Laboratories

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

• 2029年植入市场：提供新机会的国家
• 2029年植入市场：细分领域带来新机会
• 2029年植入市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手策略

第36章 附录

Bio-implants are sophisticated medical devices or prostheses crafted from materials sourced from human or animal origin, as well as biosynthetic materials. These implants serve the crucial function of replacing missing tissues and supporting damaged biological structures, ultimately enhancing the body's biological functions. Bio-implants are instrumental in assisting and regulating various human physiological functions.

Within the bio-implant category, there are several main types, including cardiovascular implants, dental implants, spinal bio-implants, orthopedic implants, ophthalmic implants, and others. Cardiovascular implants, such as heart valves and coronary stents, play a vital role in treating cardiac complications, designed to remain within a patient's body to support healthy blood arteries and a functioning heart. Bio-implants are crafted from diverse materials, including metallic, ceramic, polymer, and biological components. They originate from different sources such as allograft, autograft, xenograft, and synthetic materials. These bio-implants find application in various healthcare settings, including ambulatory surgical centers, clinics, hospitals, and other end-user facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The bio-implants market research report is one of a series of new reports from The Business Research Company that provides bio-implants market statistics, including bio-implants industry global market size, regional shares, competitors with a bio-implants market share, detailed bio-implants market segments, market trends and opportunities, and any further data you may need to thrive in the bio-implants industry. This bio-implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bio-implants market size has grown strongly in recent years. It will grow from $125.48 billion in 2024 to $136.96 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to aging population and chronic diseases, rise in surgical procedures, increased life expectancy, regulatory support and standards.

The bio-implants market size is expected to see rapid growth in the next few years. It will grow to $207.33 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to customization and personalization, growth in minimally invasive procedures, shift towards regenerative medicine, remote monitoring and telemedicine, supportive regulatory environment. Major trends in the forecast period include customized and personalized implants, biodegradable and bioresorbable implants, advancements in biomaterials, regenerative medicine and tissue engineering, smart implants and wearable technologies.

The forecast of 10.9% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply constraints for medical-grade titanium and biocompatible coatings from Italy and Sweden, which could delay orthopedic and dental implant procedures while raising costs for patients.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic conditions is anticipated to drive growth in the bio-implant market in the coming years. Chronic conditions, including cardiovascular diseases and arthritis, are defined as medical issues that persist for a year or longer, necessitate ongoing medical care, and limit daily activities. Bio-implants play a crucial role in managing and monitoring these chronic conditions, contributing to a reduction in mortality rates associated with such diseases. For instance, in July 2024, the Australian Institute of Health and Welfare reported that chronic obstructive pulmonary disease (COPD) was responsible for 7,691 deaths in Australia in 2022, equating to 29.6 deaths per 100,000 people and accounting for 4.0% of all fatalities. Therefore, the increasing prevalence of chronic conditions is propelling the growth of the bio-implant market.

The bio-implants market is experiencing growth attributed to the aging population, characterized by an increasing proportion of elderly individuals in societies. Bio implants serve diverse purposes, including real-time health monitoring, drug delivery, and tissue regeneration, catering to age-related health issues. The World Health Organization's October 2022 projections indicate a significant demographic shift, with one in six individuals globally expected to be 60 years or older by 2030. This demographic transition, marked by a rise from 1 billion in 2020 to 1.4 billion individuals aged 60 and over, is a clear indication of the increasing demand for bio-implants. Looking ahead to 2050, the global population of individuals aged 60 and older is projected to double to 2.1 billion. The aging population is thus a significant driver for the expanding bio-implants market.

In the bio-implant market, key trends are centered around technological advancements, with major players focusing on innovative biomaterial technology, particularly 3D printing for bio-implant systems. This additive manufacturing technique produces 3D structures using cells and biomaterials, deviating from traditional metals and polymers. A notable example is the March 2022 launch of Evonik Industries AG's osteoconductive VESTAKEEP iC4800 3DF PEEK filament. This high-performance polymer, based on 3D-printing technology, enhances osteointegration between bone and implant, expediting bone healing. Notable features include impressive biocompatibility, biostability, and enhanced osteoconductive qualities, reflecting the forefront of technical innovation in the bio-implant sector.

Major companies in the bio-implants market are actively introducing novel implant solutions to elevate patient care standards. Notably, the introduction of the REGENETEN Bioinductive Implant by Smith+Nephew in July 2023 stands out. This collagen-based implant supports the body's natural healing response, fostering the growth of new tendon-like tissue to reinforce existing tendons. Launched in India after completing over 100,000 global procedures, this arthroscopically delivered implant has demonstrated promising results in rotator cuff disease. Clinical trials have shown an 86% relative reduction in re-tear rates at 12 months compared to conventional surgery alone, positioning the REGENETEN Bioinductive Implant as a transformative advancement in bio-implant technology.

In August 2022, CONMED Corporation, a prominent US-based medical technology company, made a strategic move by acquiring Biorez Inc., a medical device start-up, for an undisclosed amount. This acquisition is poised to enhance CONMED's sports medicine portfolio, with the addition of Biorez bringing innovative capabilities to the forefront. The acquisition strategically positions CONMED to capitalize on emerging technologies and reinforces its commitment to growth and innovation in the competitive bio-implant market.

Major companies operating in the bio-implants market are Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Johnson & Johnson, Arthrex Inc., Boston Scientific Corporation, Smith & Nephew PLC, B. Braun Melsungen AG, Victrex PLC, Straumann Holding AG, Danaher Corporation, Cardinal Health Inc., Organogenesis Holdings Inc., Exactech Inc., Osprey Medical Inc., Edwards Lifesciences Corporation, Biotronik SE & Co. KG, aap Implantate AG, Abbott Laboratories, Biotronik Inc., Cook Medical LLC, Globus Medical Inc., Integra LifeSciences Holdings Corporation, LivaNova PLC, MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., Terumo Corporation

North America was the largest region in the bio-implants market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bio-implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bio-implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bio implants market consists of sales stents, pacing devices, orthobiologics, trauma implants, sport medicines, thoracolumber implants, intervertebral spacers, machined allograft spacers, and motion preservation implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bio-Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bio-implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bio-implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bio-implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cardiovascular Implants; Dental Implants; Spinal Bio-Implants; Orthopedic Implants; Ophthalmic Implants; Other Types
• 2) By Material: Metallic; Ceramic; Polymer; Biological
• 3) By Origin: Allograft; Autograft; Xenograft; Synthetic
• 4) By End-User: Ambulatory Surgical Centers; Clinics; Hospital; Other End-Users
• Subsegments:
• 1) By Cardiovascular Implants: Stents; Heart Valves; Pacemakers
• 2) By Dental Implants: Endosteal Implants; Subperiosteal Implants; Zygomatic Implants
• 3) By Spinal Bio-Implants: Spinal Fusion Devices; Intervertebral Discs; Spinal Rods And Plates
• 4) By Orthopedic Implants: Joint Replacement Implants; Fracture Fixation Devices; Bone Plates And Screws
• 5) By Ophthalmic Implants: Intraocular Lenses (IOLs); Retinal Implants; Corneal Implants
• 6) By Other Types: Cochlear Implants; Tissue Engineering Implants; Biomaterial Scaffolds
• Companies Mentioned: Medtronic PLC; Stryker Corporation; Zimmer Biomet Holdings Inc.; Dentsply Sirona Inc.; Johnson & Johnson; Arthrex Inc.; Boston Scientific Corporation; Smith & Nephew PLC; B. Braun Melsungen AG; Victrex PLC; Straumann Holding AG; Danaher Corporation; Cardinal Health Inc.; Organogenesis Holdings Inc.; Exactech Inc.; Osprey Medical Inc.; Edwards Lifesciences Corporation; Biotronik SE & Co. KG; aap Implantate AG; Abbott Laboratories; Biotronik Inc.; Cook Medical LLC; Globus Medical Inc.; Integra LifeSciences Holdings Corporation; LivaNova PLC; MicroPort Scientific Corporation; NuVasive Inc.; Orthofix Medical Inc.; RTI Surgical Holdings Inc.; Terumo Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bio-Implants Market Characteristics

3. Bio-Implants Market Trends And Strategies

4. Bio-Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bio-Implants Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bio-Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bio-Implants Market Growth Rate Analysis
• 5.4. Global Bio-Implants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bio-Implants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bio-Implants Total Addressable Market (TAM)

6. Bio-Implants Market Segmentation

• 6.1. Global Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Implants
• Dental Implants
• Spinal Bio-Implants
• Orthopaedic Implants
• Ophthalmic Implants
• Other Types
• 6.2. Global Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metallic
• Ceramic
• Polymer
• Biological
• 6.3. Global Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allograft
• Autograft
• Xenograft
• Synthetic
• 6.4. Global Bio-Implants Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambulatory Surgical Centers
• Clinics
• Hospital
• Other End-Users
• 6.5. Global Bio-Implants Market, Sub-Segmentation Of Cardiovascular Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stents
• Heart Valves
• Pacemakers
• 6.6. Global Bio-Implants Market, Sub-Segmentation Of Dental Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endosteal Implants
• Subperiosteal Implants
• Zygomatic Implants
• 6.7. Global Bio-Implants Market, Sub-Segmentation Of Spinal Bio-Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spinal Fusion Devices
• Intervertebral Discs
• Spinal Rods And Plates
• 6.8. Global Bio-Implants Market, Sub-Segmentation Of Orthopedic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Joint Replacement Implants
• Fracture Fixation Devices
• Bone Plates And Screws
• 6.9. Global Bio-Implants Market, Sub-Segmentation Of Ophthalmic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intraocular Lenses (IOLs)
• Retinal Implants
• Corneal Implants
• 6.10. Global Bio-Implants Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cochlear Implants
• Tissue Engineering Implants
• Biomaterial Scaffolds

7. Bio-Implants Market Regional And Country Analysis

• 7.1. Global Bio-Implants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bio-Implants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bio-Implants Market

• 8.1. Asia-Pacific Bio-Implants Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bio-Implants Market

• 9.1. China Bio-Implants Market Overview
• 9.2. China Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bio-Implants Market

• 10.1. India Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bio-Implants Market

• 11.1. Japan Bio-Implants Market Overview
• 11.2. Japan Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bio-Implants Market

• 12.1. Australia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bio-Implants Market

• 13.1. Indonesia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bio-Implants Market

• 14.1. South Korea Bio-Implants Market Overview
• 14.2. South Korea Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bio-Implants Market

• 15.1. Western Europe Bio-Implants Market Overview
• 15.2. Western Europe Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bio-Implants Market

• 16.1. UK Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bio-Implants Market

• 17.1. Germany Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bio-Implants Market

• 18.1. France Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bio-Implants Market

• 19.1. Italy Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bio-Implants Market

• 20.1. Spain Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bio-Implants Market

• 21.1. Eastern Europe Bio-Implants Market Overview
• 21.2. Eastern Europe Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bio-Implants Market

• 22.1. Russia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bio-Implants Market

• 23.1. North America Bio-Implants Market Overview
• 23.2. North America Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bio-Implants Market

• 24.1. USA Bio-Implants Market Overview
• 24.2. USA Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bio-Implants Market

• 25.1. Canada Bio-Implants Market Overview
• 25.2. Canada Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bio-Implants Market

• 26.1. South America Bio-Implants Market Overview
• 26.2. South America Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bio-Implants Market

• 27.1. Brazil Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bio-Implants Market

• 28.1. Middle East Bio-Implants Market Overview
• 28.2. Middle East Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bio-Implants Market

• 29.1. Africa Bio-Implants Market Overview
• 29.2. Africa Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bio-Implants Market Competitive Landscape And Company Profiles

• 30.1. Bio-Implants Market Competitive Landscape
• 30.2. Bio-Implants Market Company Profiles
  • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Dentsply Sirona Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

31. Bio-Implants Market Other Major And Innovative Companies

• 31.1. Arthrex Inc.
• 31.2. Boston Scientific Corporation
• 31.3. Smith & Nephew PLC
• 31.4. B. Braun Melsungen AG
• 31.5. Victrex PLC
• 31.6. Straumann Holding AG
• 31.7. Danaher Corporation
• 31.8. Cardinal Health Inc.
• 31.9. Organogenesis Holdings Inc.
• 31.10. Exactech Inc.
• 31.11. Osprey Medical Inc.
• 31.12. Edwards Lifesciences Corporation
• 31.13. Biotronik SE & Co. KG
• 31.14. aap Implantate AG
• 31.15. Abbott Laboratories

32. Global Bio-Implants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bio-Implants Market

34. Recent Developments In The Bio-Implants Market

35. Bio-Implants Market High Potential Countries, Segments and Strategies

• 35.1 Bio-Implants Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bio-Implants Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bio-Implants Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer